桂枝茯苓胶囊联合米非司酮治疗子宫肌瘤的临床观察

发布时间：2018-09-09 18:32

【摘要】：目的观察米非司酮配伍桂枝茯苓胶囊治疗子宫肌瘤的疗效。方法将2008～2010年就诊的绝经前有症状的子宫肌瘤患者150例随机分为观察组和对照组,各75例,两组均从月经来潮第1天开始服用米非司酮片;观察组在月经干净后加服桂枝茯苓胶囊。观察治疗后两组疗效。结果服药1个月后两组患者均出现闭经,痛经症状逐渐消失,贫血患者均得到纠正。临床显效率和总有效率观察组分别为52.0%和92.0%,对照组分别为36.0%和81.3%,两组间比较差异有统计学意义(P0.05)。结论桂枝茯苓胶囊联合米非司酮较单独应用米非司酮治疗子宫肌瘤疗效更好,适用于术前或围绝经期保守治疗子宫肌瘤。
[Abstract]:Objective to observe the efficacy of mifepristone combined with Guizhi Fuling capsule in the treatment of uterine leiomyoma. Methods from 2008 to 2010, 150 patients with premenopausal myoma were randomly divided into two groups: observation group (75 cases) and control group (75 cases). Both groups took mifepristone tablets from the 1st day of menstrual cycle. Observe group after menstruation is clean add take Guizhi Fuling capsule. Observe the curative effect of the two groups after treatment. Results one month after taking medicine, amenorrhea appeared in both groups, dysmenorrhea gradually disappeared and anemia patients were corrected. The clinical effective rate and total effective rate were 52.0% and 92.0% in the observation group and 36.0% and 81.3% in the control group respectively. The difference between the two groups was statistically significant (P0.05). Conclusion Guizhi Fuling capsule combined with mifepristone is more effective than mifepristone alone in the treatment of uterine leiomyoma. It is suitable for conservative treatment of uterine leiomyoma before or after menopause.
【作者单位】：汕头市第四人民医院妇产科;汕头市金园中医院内科;
【分类号】：R737.33

【参考文献】